← Back to Search

Virus Therapy

Flocked swab paired with Roche Cobas 4800 for Cervical Cancer (ACCESS Trial)

N/A
Waitlist Available
Led By Darcy Rao, PhD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during study year 1
Awards & highlights

ACCESS Trial Summary

This trial is evaluating whether self-collection of vaginal samples for HPV testing is an effective alternative cervical cancer screening strategy for persons with HIV and/or limited access to care.

Eligible Conditions
  • Cervical Cancer

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during study year 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and during study year 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Confidence with self-collection
Ease of returning home kits
Proportion of eligible individuals who accept self-sampling kits
+3 more
Secondary outcome measures
Attitudes and preferences for screening
Colposcopy results checklist
HPV prevalence checklist
+6 more

ACCESS Trial Design

1Treatment groups
Experimental Treatment
Group I: HPV self-samplingExperimental Treatment1 Intervention
Participants will be offered self-collection kits for HPV-based cervical cancer screening.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,301 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
401,680 Total Patients Enrolled
Darcy Rao, PhD, MPHPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals
Darcy W Rao, PhD 2022. "HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05528237.
All > Cervical Cancer
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top